| SCILEX HLDG CO. O.N. |
| USA |
| US80880W2052 / A412WV |
| D8B0 (Frankfurt) / SCLX (NASDAQ) |
| FRA:D8B0, ETR:D8B0, D8B0:GR, NASDAQ:SCLX |
| - |
| - |
|
Scilex Holding Company is an innovative biopharmaceutical firm focused on acquiring, developing, and commercializing non-opioid pain management products for acute and chronic pain treatment. Its portfolio features ZTLido, a proprietary patch with adv..
>Volltext.. |
| 57.98 Mio. EUR |
| 143.79 Mio. EUR |
| 29.61 Mio. EUR |
| -236.13 Mio. EUR |
| -366.92 Mio. EUR |
| -35.48 EUR |
| 92.99 Mio. EUR |
| 2.93 Mio. EUR |
| -2.86 Mio. EUR |
| 0.01 |
| -33.22% |
| -463.25% |
| - |
| - |
| - |
| - |
| 06.07.26 |
|